Clinical Trials Browser

Phase 2 × NETWORK × Aspirin × Clear all

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Phase 2 Active not recruiting

Ovarian Cancer Prevention

NCT02659384 2023-03-14

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms